July 26, 2024
Washington DC’s 60 Degrees Pharmaceuticals Awarded Contract with U.S. Army for ARAKODA® Supply Chain Upgrade Support
WASHINGTON, July 25, 2024 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical company focused on developing new…
July 24, 2024
BioHealth Capital Region Retains #3 Spot in GEN’s Top U.S. Biopharma Clusters for 2024
The BioHealth Capital Region (Maryland, Virginia, and Washington, D.C.) has successfully retained its position as the #3 biopharma cluster in…
July 24, 2024
MedCityNews: How Startup miRecule Leveraged Its RNA Platform Tech to Land a Sanofi Alliance
RNA therapies developer miRecule is partnered with Sanofi on the development of a treatment for facioscapulohumeral muscular dystrophy, or FSHD.…
July 24, 2024
Mirecule Wins MedCity INVEST 2024 Competition
Chicago, May 2024 — miRecule, a cutting-edge startup focused on developing antibody RNA conjugate therapeutics, clinched the top spot at…
July 24, 2024
TEDCO Announces SSBCI Investment in Solaxa Inc.
Maryland-based biopharmaceutical company receives funding from TEDCO’s Venture Funds' COLUMBIA, Md., (July 23, 2024) — TEDCO, Maryland’s economic engine for technology companies,…
July 23, 2024
Precigen Appoints Phil Tennant as Chief Commercial Officer to Spearhead First Potential Gene Therapy Launch
GERMANTOWN, Md., July 23, 2024 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to…